Clinical-Stage Biotech Stock Might Outperform Amgen Post author:Sam Post published:February 8, 2018 Post category:BioPharma This biotech could potentially could be a better value. Source: BioSpace You Might Also Like AntriaBio Announces $13 Million Close Of Private Placement Transaction And Plan To Dose First Patient With AB101 This Month July 17, 2017 3 Biotechs Leading the Pack in The Hepatitis B Space April 13, 2017 Halozyme To Host Second Quarter 2017 Financial Results Conference Call July 10, 2017
AntriaBio Announces $13 Million Close Of Private Placement Transaction And Plan To Dose First Patient With AB101 This Month July 17, 2017
